In one paragraphArticle in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
George R BigginManchester Cell Matrix Centre, University of Manchester, Manchester, UK.
Yu-Bai Xiao *School of Mechanical, Aerospace, and Manufacturing Engineering, University of Connecticut, Storrs, US.ORCID 0000-0001-8733-0405 Catherine SmedleyManchester Cell Matrix Centre, University of Manchester, Manchester, UK.
Rana DajaniManchester Cell Matrix Centre, University of Manchester, Manchester, UK.
Holly L BirchenoughManchester Cell Matrix Centre, University of Manchester, Manchester, UK.
Thomas A JowittManchester Cell Matrix Centre, University of Manchester, Manchester, UK.
Alan M RosemanDivision of Molecular and Cellular Function, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID 0000-0002-4783-2619 Anna TarakanovaSchool of Mechanical, Aerospace, and Manufacturing Engineering, University of Connecticut, Storrs, US.ORCID 0000-0002-6093-031X Clair BaldockManchester Cell Matrix Centre, University of Manchester, Manchester, UK. clair.baldock@manchester.ac.uk.ORCID 0000-0003-3497-1959 Funding
Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related GenesU01HL146188 · NHLBI · GEISINGER CLINIC · PI BOEHM, MANFRED, WILLIAMS, MARC S. · 2020 to 2024
$3.1MMultiscale Effects of Aging on Elastic Arterial Tissue MechanicsR01AG084715 · NIA · UNIVERSITY OF CONNECTICUT STORRS · PI Anna Tarakanova · 2024 to 2026
$1.8MMultiscale Effects of Aging on Elastic Arterial Tissue MechanicsR56AG075690 · NIA · UNIVERSITY OF CONNECTICUT STORRS · PI TARAKANOVA, ANNA · 2023 to 2023
$280kBBSRC BB/T017643/1National Science Foundation (NSF) ACI-1548562NHLBI NIH HHS U01 HL146188NIA NIH HHS R01 AG084715NIA NIH HHS R56 AG075690NSF | ENG/OAD | Division of Civil, Mechanical and Manufacturing Innovation (CMMI) 2145759RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/T008725/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/V008099/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/V015826/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/Y011740/1RCUK | Medical Research Council (MRC) MR/V011243/1U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) 5U01HL146188U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) 1R01AG084715U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) 1R56AG075690-01A1Wellcome TrustWellcome Trust (Wellcome) 208398/Z/17/Z
6 · The paper itselfAbstract
Transforming growth factor-β (TGFβ) is a potent cytokine that controls all aspects of cellular behavior. TGFβ is secreted in complex with its prodomain and latent TGFβ-binding protein-1 (LTBP1), forming the large latent complex (LLC), which through interaction with the extracellular matrix enables integrin-mediated activation. Although TGFβ structures are known, the influence of LTBP1 on the structure and activity of TGFβ is unknown. Here, we report the LLC cryo-EM structure comprising the LTBP1 eight-cysteine domain covalently bound to TGFβ, revealing a hydrophobic interface between TGFβ and LTBP1. Structure-guided mutagenesis shows that the interface is important for complex formation and TGFβ activity. Our structure supports a contralateral domain swapped architecture in the LLC, and simulations show that this architecture requires increased force to overcome barriers for integrin-mediated activation, while the covalent attachment of TGFβ to LTBP1 redistributes force to reduce unfolding barriers. These insights will be important for therapeutic strategies targeting TGFβ.
Indexed as
Latent TGF-beta Binding ProteinsTransforming Growth Factor betaAnimalsCryoelectron MicroscopyCysteineHumansModels, MolecularProtein BindingProtein DomainsCysteineLatent TGF-beta Binding ProteinsLTBP1 protein, humanTransforming Growth Factor beta
Identifiers
PMID42557249
PMCPMC13443091
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390